Oncology

HPV vaccine ‘means women only need three cervical scans through life’

Women may only have to undergo three cervical screens in their lifetimes if they have received the human papillomavirus (HPV) vaccine, according to a new study by Queen Mary University of London (QMUL), UK. The research found that three smear tests at the ages of 30, 40 and 55 would offer the same...

Regular exercise can reduce breast cancer treatment side effects

Regular exercise can reduce the side effects of treatment for advanced breast cancer, including fatigue and pain, as well as improve cardiovascular health and quality of life, according to new research. Led by the University of Porto in Portugal, the new research suggests that women with advanced...

Researchers track mammary cell changes that lead to breast cancer

Researchers have mapped early genetic alterations in normal-looking cells at various distances from primary tumours to show how changes along the lining of mammary ducts can lead to breast cancer. The study was conducted by a multidisciplinary team, led by principal investigator Dr Susan Done...

New blood test to diagnose ovarian cancer developed

Researchers have identified a network of circulating microRNAs - small, non-coding pieces of genetic material - that are associated with a risk of ovarian cancer and can be detected from blood samples. The team, from Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute, US, said...

Pregnancy ‘does not pose breast cancer relapse risk’

Pregnancy does not incur a greater risk of relapse for survivors of breast cancer, according to a study by an international group of researchers. Published in the Journal of the National Cancer Institute, the study compared breast cancer survivors who became pregnant with those who did not become...

Study reveals clues to mechanisms of breast cancer

An international collaboration has identified 72 new genetic variants that contribute to the risk of developing breast cancer. Of these, the researchers revealed, 65 are common variants that predispose to breast cancer and a further seven predispose specifically to oestrogen-receptor negative...

Ovarian cancer ‘may begin in fallopian tubes’

The genomic roots of many ovarian cancer tumours may begin in the fallopian tubes, according to a new study. According to the researchers, this discovery can potentially provide insights into the origin of ovarian cancer and suggest new ways for prevention and intervention of the disease. They...

Cancer linked with breast implants ‘may be underreported’

A rare cancer developed by some patients with breast implants may be on the rise, but not all patients or doctors are aware of the risks of augmentation, according to new research. Scientists from Penn State College of Medicine explained that breast implant-associated anaplastic large cell lymphoma...

Machine learning can identify pre-breast cancer lesions

A machine learning tool has the ability to help identify which high-risk breast lesions are likely to become cancerous, according to a new study by Massachusetts General Hospital (MGH), US. Researchers said the technology has the potential to reduce unnecessary surgeries. High-risk breast lesions...

Higher lymphocyte infiltration predicts increased ovarian cancer survival rates

A new study from the Mayo Clinic and University of New South Wales Sydney has revealed how levels of immune response could be used to predict survival rates in patients with ovarian cancer. Published by the Ovarian Tumor Tissue Analysis Consortium in JAMA Oncology, the research examined levels of a...